Company: SWKH
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001628280-25-025955
Chunk: 29

Company: SWK Holdings Corp
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 29
---
, net209 209 Other non-current assets1,150 1,200 Total assets held for sale, net$6,409 $6,398 Liabilities:Accounts payable & accrued liabilities$298 $268 Other non-current liabilities1,027 987 Total liabilities held for sale$1,325 $1,255 During neither the three months ended March 31, 2025 nor the year ended December 31, 2024, there was not a strategic shift for the Company, and accordingly, the Pharmaceutical Development segment does not meet the criteria to be classified as a discontinued operation. As a result, we will continue to report our operational results for the Pharmaceutical Development segment until the sale. The following table shows the net loss before taxes for MOD3 (in thousands):Three Months Ended March 31,20252024Net loss before taxes$(536)$(1,453)

Note 5. Marketable Investments

Investments in corporate debt and equity securities consist of the following (in thousands):March 31, 2025December 31, 2024Corporate debt securities$13 $21 Equity securities442 559 Total marketable investments$455 $580  The amortized cost basis amounts, gross unrealized holding gains, gross unrealized holding losses and fair values of available-for-sale debt securities are as follows (in thousands):Amortized CostGross Unrealized Gains Gross Unrealized LossesFair ValueMarch 31, 2025$13 $— $— $13 December 31, 2024$21 $— $— $21 

14

Equity SecuritiesOn June 30, 2024, the Company exercised its right to purchase AOTI, Inc ("AOTI") restricted stock. Upon exercise, the Company received 402,634 shares of AOTI restricted stock with a fair value of $0.7 million, or $1.68 per share. The restricted stock can be converted into publicly traded common shares one year after the exercise date. The following table presents gains and losses on equity securities as prescribed by ASC 321, Investments - Equity Securities (in thousands):Three Months Ended March 31,2025Unrealized loss on equity securities held at the end of the period$(105)

Note 6. Debt

Revolving Credit FacilityOn June 28, 2023, the Company entered into a new credit agreement (the “